2023 CIMT
Annual Meeting

SAVE THE DATE:
May 3-5, 2023

Europe's Cancer Immunotherapy Meeting

Speakers & Program

Our 2022 Supporters

CIMT News

December 21, 2021
This is some text inside of a div block.

CIMT Annual Meeting 2022 program to again showcase hottest topics in cancer immunotherapy

From cutting-edge basic research to the latest translational applications, the 2022CIMT Annual Meeting will again cover the latest advances in the field. Stay tuned for more information to be posted in January.

Read more
August 11, 2022
2022-08-11 12:16

CIMT 2023

Save the date for the 20th CIMT Annual Meeting on May 3-5, 2023.

May 12, 2022
2022-05-17 16:15

2022 Poster Award Winners

Seven early-career researchers were chosen by the CIMT poster jury members to receive the 2022 CIMT Poster Awards in six categories.

Read more
May 10, 2022
2022-05-10 15:16

CIMT 2022 opens in Mainz, Germany

The 2022 Annual Meeting today opened with over 700 international participants on-site and an additional livestream audience, totaling close to 1,000 attendees.

Read more
May 5, 2022
2022-05-05 16:11

COVID-19 protective measures

CIMT asks all on-site attendees to wear a surgical or FFP2/KN95 mask at the meeting.

Read more
April 21, 2022
2022-04-21 12:38

Detailed program schedule

A detailed program schedule with all 2022 speakers and talk titles is now published online.

Read more
April 13, 2022
2022-04-13 17:36

Poster and short talk presenters notified

All abstract authors have been notified about their scheduled poster presentations.

Read more
March 11, 2022
2022-03-11 13:42

New registration deadline

The advanced registration deadline has been extended through March 13, midnight (CET).

March 4, 2022
2022-03-07 9:22

Extended abstract submission deadline

The 2022 abstract submission deadline has been extended through March 13, midnight (CET).

January 21, 2022
2022-01-21 15:35

Abstract submission is open

The CIMT program committee is calling for abstract submission through March 4, 2022.

December 22, 2021
2021-12-22 12:27

CIMT Annual Meeting 2022

From cutting-edge basic research to the latest translational studies, the 2022 CIMT Annual Meeting will again cover the newest advances in the field.

Read more
September 17, 2021
2021-12-07 19:33

Save the Date for CIMT 2022

The 2022 CIMT Annual Meeting will take place May 10-12, 2022. More information will be posted as it becomes available.

read more
June 10, 2021
2021-12-07 19:35

On-demand viewing is available

The 2021 Annual Meeting sessions and eTalks have been available for on-demand viewing on the virtual event platform since May 31.

read more
May 19, 2021
2021-12-07 21:36

ACIR meeting summary

Selected talks from the virtual 18th CIMT Annual Meeting, including the keynote lecture by Ugur Sahin, were covered by ACIR. The meeting summary can be accessed on the ACIR web page.

read more
May 18, 2021
2021-12-07 21:36

On-demand session viewing

The Annual Meeting virtual platform is currently under construction. Thank you for your patience while we prepare the session talks for on-demand viewing. The platform will re-open at the end of May.

read more
May 14, 2021
2021-12-07 21:38

2021 eTalk Award Winners

Six early-career researchers have been chosen by the CIMT poster jury to receive the 2021 CIMT Poster Awards. One eTalk winner was selected by the meeting audience.

read more
May 10, 2021
2021-12-07 21:39

CIMT 2021 opens in Mainz, Germany

The virtual 18th Annual Meeting of the Association for Cancer Immunotherapy CIMT was opened  today by CIMT President Özlem Türeci  with over 800 academic and clinical professionals.

read more
May 3, 2021
2021-12-07 21:42

2021 abstracts are online

All abstracts and the day-to-day 2021 Annual Meeting program are online can be accessed at www.meeting.cimt.eu/speakers-and-program.

read more
April 28, 2021
2021-12-07 21:43

2021 CIMT Lifetime Achievement Award

The Italian immunologist Alberto Mantovani will be honored by CIMT for life-time achievements in cancer immunotherapy research.

read more
April 16, 2021
2021-12-07 21:43

Abstract authors have been notified

All abstract authors have been notified and have been sent information about setting up their presentations. The CIMT eTalk sessions will feature a total of 221 scientific eTalks.

read more
March 12, 2021
2021-12-07 21:44

Abstract submission extended to March 24

For late breaking abstracts, the 2021 abstract submission and advance registration has been extended to March 24 (midnight CET).

read more
February 25, 2021
2021-12-07 21:44

Apply for a registration waiver

CIMT will select young scientists from underrepresented countries for free conference admission. Free conference admission can only be extended to scientists under certain conditions.

read more
January 29, 2021
2021-12-07 21:45

2021 registration and abstract submission is open

For its virtual congress, the CIMT program committee is calling for abstract submission in six  categories: Therapeutic Vaccination, Cellular Therapy, New Targets and New Leads, and more.

read more
November 23, 2020
2021-12-07 21:46

2021 CIMT Annual Meeting

Save the date for the 2021 CIMT Annual Meeting which will take place in a virtual format, from May 10-12, 2021.

read more
March 20, 2020
2021-12-07 21:46

The 2020 CIMT Annual Meeting will not take place

The CIMT Executive Board has decided to not hold the CIMT Annual Meeting, which was scheduled for May 5-7, 2020, in Mainz, Germany.

read more

Join the CIMT Experience

Welcome to Europe’s largest meeting focused on cancer immunotherapy research and development. Every year, the CIMT Annual Meeting connects the global cancer immunotherapy community in the heart of Europe. As the largest meeting focused on cancer immunotherapy research and development in Europe, CIMT invites international participants for high-level scientific exchange, collaboration, and education focused on cancer immunotherapy.

2022 Plenary Speakers

Luca Gattinoni
Leibniz Institute for Immunotherapy (LIT)
Regensburg, Germany
Robbie Majzner
Stanford University School of Medicine
Palo Alto, USA
Megan Burger
Koch Institute at MIT
Cambridge, USA
Martina Seiffert
German Cancer Research Center (DKFZ)
Heidelberg, Germany
All Speakers

20 Years CIMT - 20 Years of Fostering Cancer Immunotherapies

The Association for Cancer Immunotherapy CIMT is a members-based information and education platform that facilitates the knowledge exchange between academic and industry scientists, physicians and regulatory authorities who research and develop cancer immunotherapies. CIMT was founded in 2002 by physicians and researchers from different fields of clinical and theoretical medicine as an independent non-profit organization. Since 2003, CIMT has organized annual expert meetings on cancer immunotherapy research and clinical translation. CIMT has its offices in Mainz, Germany, and is financed by donations, congress fees, industry sponsorship and by public and foundation grants.

Learn more about CIMT
Watch the Video

Subscribe to the CIMT newsletter

Stay up to date on Europe’s largest meeting focused on cancer immunotherapy research and development